# Natural History of COVID-19-Related Atrial Fibrillation

Study · id `cardio:ct-nct04830774` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04830774](<https://clinicaltrials.gov/study/NCT04830774>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04830774

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04830774. Allocation not applicable; no masking; primary purpose screening. Start 2021-04-15 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04830774, source copy `cardio:ctgov-nct04830774-2021-11-23`, retrieved 2026-10-26)
- Started: 2021-04-15 (actual) (ClinicalTrials.gov record NCT04830774, source copy `cardio:ctgov-nct04830774-2021-11-23`, retrieved 2026-10-26)
- Primary completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT04830774, source copy `cardio:ctgov-nct04830774-2021-11-23`, retrieved 2026-10-26)
- Completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT04830774, source copy `cardio:ctgov-nct04830774-2021-11-23`, retrieved 2026-10-26)
- Countries: United States; Belgium; Italy (ClinicalTrials.gov record NCT04830774, source copy `cardio:ctgov-nct04830774-2021-11-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04830774-2021-11-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Natural History of COVID-19-Related Atrial Fibrillation
- Acronym: unCOVer-AF
- Condition: COVID-19
- Condition: Atrial Fibrillation New Onset
- Intervention (Device): ILR, PMK, ICD
- Lead sponsor: Texas Cardiac Arrhythmia Research Foundation
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Texas Cardiac Arrhythmia Research Foundation (`cardio:org-texas-cardiac-arrhythmia-research-foundation`)

## Provenance

Content hash: 95265407ebfdbac98f1e3bedeb4975f661a9d3047f9d689fae482c9da420d5db
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
